About Us
RaviRas Therapeutics
RaviRas therapeutics is a drug discovery and drug development LLC biopharma company mainly focusing on the most prevalent target, RAS, in solid and blood cancer models. Our goal is to develop novel small molecule allosteric binding region inhibitors that are selectively targeting specific mutant alleles of RAS oncogenes. The RaviRas therapeutics drug discovery team has extensive small molecule drug development expertise and substantial research experience in the RAS target biology. RaviRas therapeutics office is based in Boston, MA, a hotbed of Pharma drug development.








